Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P LAMBIN

Showing results (191-200 of 215) with videos related to

Pageof 22
Sort By:
British Journal of Cancer|May 8, 2015
Different prognostic models for different patient populations: validation of a new prognostic model for patients with oropharyngeal cancer in Western EuropeM M Rietbergen, B I Witte, E R Velazquez, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 23, 2008
Eligibility for concurrent chemotherapy and radiotherapy of locally advanced lung cancer patients: a prospective, population-based studyD De Ruysscher, A Botterweck, M Dirx, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 23, 2015
Nomograms to predict survival and the risk for developing local or distant recurrence in patients with rectal cancer treated with optional short-term radiotherapyW van Gijn, R G P M van Stiphout, C J H van de Velde, et al.
Blood|November 26, 1999
Erythroblastic synartesis: an auto-immune dyserythropoiesisE M Cramer, I Garcia, J M Massé, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 19, 2013
Characterization of tumor heterogeneity using dynamic contrast enhanced CT and FDG-PET in non-small cell lung cancerW van Elmpt, M Das, Martin Hüllner, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 7, 2024
Intratumor genetic heterogeneity and head and neck cancer relapseA S Pierik, J B Poell, A Brink, et al.
British Journal of Cancer|October 7, 2006
Repeated cycles of Clostridium-directed enzyme prodrug therapy result in sustained antitumour effects in vivoJ Theys, O Pennington, L Dubois, et al.
Nuclear Medicine Communications|March 22, 2001
The utility of SPECT in determining the relationship between radiation dose and salivary gland dysfunction after radiotherapyF van Acker, P Flamen, P Lambin, et al.
Medical Physics|February 25, 2009
Prediction of DVH parameter changes due to setup errors for breast cancer treatment based on 2D portal dosimetryS M J J G Nijsten, W J C van Elmpt, B J Mijnheer, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|May 1, 2012
Radiation-induced oesophagitis in lung cancer patients. Is susceptibility for neutropenia a risk factor?D De Ruysscher, J Van Meerbeeck, K Vandecasteele, et al.
Pageof 22

Showing results (191-200 of 215) with videos related to

Sort By:
Pageof 22
British Journal of Cancer|May 8, 2015
Different prognostic models for different patient populations: validation of a new prognostic model for patients with oropharyngeal cancer in Western EuropeM M Rietbergen, B I Witte, E R Velazquez, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 23, 2008
Eligibility for concurrent chemotherapy and radiotherapy of locally advanced lung cancer patients: a prospective, population-based studyD De Ruysscher, A Botterweck, M Dirx, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 23, 2015
Nomograms to predict survival and the risk for developing local or distant recurrence in patients with rectal cancer treated with optional short-term radiotherapyW van Gijn, R G P M van Stiphout, C J H van de Velde, et al.
Blood|November 26, 1999
Erythroblastic synartesis: an auto-immune dyserythropoiesisE M Cramer, I Garcia, J M Massé, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 19, 2013
Characterization of tumor heterogeneity using dynamic contrast enhanced CT and FDG-PET in non-small cell lung cancerW van Elmpt, M Das, Martin Hüllner, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|January 7, 2024
Intratumor genetic heterogeneity and head and neck cancer relapseA S Pierik, J B Poell, A Brink, et al.
British Journal of Cancer|October 7, 2006
Repeated cycles of Clostridium-directed enzyme prodrug therapy result in sustained antitumour effects in vivoJ Theys, O Pennington, L Dubois, et al.
Nuclear Medicine Communications|March 22, 2001
The utility of SPECT in determining the relationship between radiation dose and salivary gland dysfunction after radiotherapyF van Acker, P Flamen, P Lambin, et al.
Medical Physics|February 25, 2009
Prediction of DVH parameter changes due to setup errors for breast cancer treatment based on 2D portal dosimetryS M J J G Nijsten, W J C van Elmpt, B J Mijnheer, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|May 1, 2012
Radiation-induced oesophagitis in lung cancer patients. Is susceptibility for neutropenia a risk factor?D De Ruysscher, J Van Meerbeeck, K Vandecasteele, et al.
Pageof 22